These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 26887977)

  • 1. GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification.
    Chung VY; Tan TZ; Tan M; Wong MK; Kuay KT; Yang Z; Ye J; Muller J; Koh CM; Guccione E; Thiery JP; Huang RY
    Sci Rep; 2016 Feb; 6():19943. PubMed ID: 26887977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The GRHL2/ZEB Feedback Loop-A Key Axis in the Regulation of EMT in Breast Cancer.
    Mooney SM; Talebian V; Jolly MK; Jia D; Gromala M; Levine H; McConkey BJ
    J Cell Biochem; 2017 Sep; 118(9):2559-2570. PubMed ID: 28266048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transcription factor ZEB1 mediates the progression of epithelial ovarian cancer by promoting the transcription of CircANKRD17.
    Cai W; Zhang Q
    J Biochem Mol Toxicol; 2022 Aug; 36(8):e23086. PubMed ID: 35521974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of the grainyhead transcription factor 2 gene (GRHL2) inhibits the proliferation, migration, invasion and mediates cell cycle arrest of ovarian cancer cells.
    Faddaoui A; Sheta R; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Gobeil S; Morin C; Ghani K; Bachvarov D
    Cell Cycle; 2017 Apr; 16(7):693-706. PubMed ID: 28278050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells.
    Tryndyak VP; Beland FA; Pogribny IP
    Int J Cancer; 2010 Jun; 126(11):2575-83. PubMed ID: 19839049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial-mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and Grainyhead-like-2.
    Cieply B; Farris J; Denvir J; Ford HL; Frisch SM
    Cancer Res; 2013 Oct; 73(20):6299-309. PubMed ID: 23943797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p63 Gene Is Regulated by Grainyhead-like 2 (GRHL2) through Reciprocal Feedback and Determines the Epithelial Phenotype in Human Keratinocytes.
    Mehrazarin S; Chen W; Oh JE; Liu ZX; Kang KL; Yi JK; Kim RH; Shin KH; Park NH; Kang MK
    J Biol Chem; 2015 Aug; 290(32):19999-20008. PubMed ID: 26085095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of
    Carpinelli MR; de Vries ME; Auden A; Butt T; Deng Z; Partridge DD; Miles LB; Georgy SR; Haigh JJ; Darido C; Brabletz S; Brabletz T; Stemmler MP; Dworkin S; Jane SM
    Dis Model Mech; 2020 Mar; 13(3):. PubMed ID: 32005677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal-Epithelial Transition in Sarcomas Is Controlled by the Combinatorial Expression of MicroRNA 200s and GRHL2.
    Somarelli JA; Shetler S; Jolly MK; Wang X; Bartholf Dewitt S; Hish AJ; Gilja S; Eward WC; Ware KE; Levine H; Armstrong AJ; Garcia-Blanco MA
    Mol Cell Biol; 2016 Oct; 36(19):2503-13. PubMed ID: 27402864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
    Yang Z; Wu D; Chen Y; Min Z; Quan Y
    Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
    Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
    Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-150 predicts a favorable prognosis in patients with epithelial ovarian cancer, and inhibits cell invasion and metastasis by suppressing transcriptional repressor ZEB1.
    Jin M; Yang Z; Ye W; Xu H; Hua X
    PLoS One; 2014; 9(8):e103965. PubMed ID: 25090005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of the hybrid epithelial/mesenchymal phenotype.
    Jolly MK; Tripathi SC; Jia D; Mooney SM; Celiktas M; Hanash SM; Mani SA; Pienta KJ; Ben-Jacob E; Levine H
    Oncotarget; 2016 May; 7(19):27067-84. PubMed ID: 27008704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma.
    Kurashige J; Kamohara H; Watanabe M; Hiyoshi Y; Iwatsuki M; Tanaka Y; Kinoshita K; Saito S; Baba Y; Baba H
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S656-64. PubMed ID: 22311119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-derived extracellular vesicles containing microRNA-1290 promote immune escape of cancer cells through the Grhl2/ZEB1/PD-L1 axis in gastric cancer.
    Liang Y; Liu Y; Zhang Q; Zhang H; Du J
    Transl Res; 2021 May; 231():102-112. PubMed ID: 33321257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-205 promotes motility of ovarian cancer cells via targeting ZEB1.
    Niu K; Shen W; Zhang Y; Zhao Y; Lu Y
    Gene; 2015 Dec; 574(2):330-6. PubMed ID: 26275944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer.
    Stinson S; Lackner MR; Adai AT; Yu N; Kim HJ; O'Brien C; Spoerke J; Jhunjhunwala S; Boyd Z; Januario T; Newman RJ; Yue P; Bourgon R; Modrusan Z; Stern HM; Warming S; de Sauvage FJ; Amler L; Yeh RF; Dornan D
    Sci Signal; 2011 Aug; 4(186):pt5. PubMed ID: 21868360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of GRHL2 and epigenetic remodeling in epithelial-mesenchymal plasticity in ovarian cancer cells.
    Chung VY; Tan TZ; Ye J; Huang RL; Lai HC; Kappei D; Wollmann H; Guccione E; Huang RY
    Commun Biol; 2019; 2():272. PubMed ID: 31372511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes.
    Zhao S; Zhang Y; Zheng X; Tu X; Li H; Chen J; Zang Y; Zhang J
    J Cell Physiol; 2015 Nov; 230(11):2706-17. PubMed ID: 25808945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ELF3 promotes epithelial-mesenchymal transition by protecting ZEB1 from miR-141-3p-mediated silencing in hepatocellular carcinoma.
    Zheng L; Xu M; Xu J; Wu K; Fang Q; Liang Y; Zhou S; Cen D; Ji L; Han W; Cai X
    Cell Death Dis; 2018 Mar; 9(3):387. PubMed ID: 29523781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.